| Lot Release Number |
2021-02-19-0075
|
| FDA Registered Product/Generic Name |
Diphtheria, Tetanus and Pertussis (acellular component), Hepatitis B (rDNA), Poliomyelitis (inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (adsorbed)
|
| Brand Name |
Infanrix Hexa
|
| Dosage Strength |
0.5 mL
|
| Dosage Form |
Suspension for Injection
|
| Registration Number |
BR-508
|
| Batch/Lot Number |
AC21B766B (DTPa component) / AHIBD429C (Hib component)
|
| Packaging Lot |
Packaging Lot (Box): A21CD854A
Pre-filled syringe: A21LD854A, MD 02-2020, ED 01-2023
Vial: A21FD854A, MD 05-2020, ED 04-2023;
Needles (25G x 1"): 200438, ED 2025-03-31
|
| Product Expiration Date |
31 January 2023
|
| Issuance Date |
23 February 2021
|